A Sleep Intervention for Cancer Patients and Their Caregivers
1 other identifier
interventional
2
1 country
1
Brief Summary
The purpose of the study is to design and test a dyadic sleep intervention for patients diagnosed with cancer and their intimate partner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2016
CompletedFirst Submitted
Initial submission to the registry
July 16, 2021
CompletedFirst Posted
Study publicly available on registry
July 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2026
CompletedApril 9, 2026
April 1, 2026
9.3 years
July 16, 2021
April 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Insomnia Severity Index
Insomnia Reduction by 50% -Total Score (0-28, where 28 is most severe)
Change from baseline in insomnia reduction at 6 months
Insomnia Severity Index
Insomnia Reduction by 50% -Total Score (0-28, where 28 is most severe)
Change from baseline in insomnia reduction at 12 months
Secondary Outcomes (4)
Pittsburgh Sleep Quality Index (PSQI)
Change from baseline in improved sleep latency at 6 months.
Pittsburgh Sleep Quality Index (PSQI)
Change from baseline in improved sleep latency at 12 months
Patient-reported Outcomes Measurement Information System (PROMIS-29)
Change from baseline in improved quality of life at 6 months
Patient-reported Outcomes Measurement Information System (PROMIS-29)
Change from baseline in improved quality of life at 12 months
Other Outcomes (2)
Patient-reported Outcomes Measurement Information System (PROMIS-29)
Change from baseline in depressive symptoms at 6 months
Patient-reported Outcomes Measurement Information System (PROMIS-29)
Change from baseline in depressive symptoms at 12 months
Study Arms (2)
Modified Cognitive Behavioral Therapy Intervention Dyadic
EXPERIMENTALThe patient and caregiver in the dyadic intervention will have 5 sessions of Modified CBTi. The patient and caregiver will complete the assessment at 3- and 6 months follow up.
Modified Cognitive Behavioral Therapy Intervention Patient Only
EXPERIMENTALThe patient in the patient only intervention arm will receive 5 sessions of Modified CBTi. The patient and caregiver will complete the assessment at 3- and 6 months follow up
Interventions
The patient and caregiver dyads will complete and return baseline questionnaires and then be randomized to Modified CBTi Dyadic Intervention. The patient and caregiver in the dyadic intervention will have 5 sessions of Modified CBTi. Upon completion of the intervention, the patient and caregiver will complete the follow up assessments at approximately 3 months and 6 months after the baseline questionnaires.
The patient and caregiver dyads will complete and return baseline questionnaires and then be randomized to Modified CBTi Patient Only Intervention. The patient in the Patient Only Intervention will have 5 sessions of Modified CBTi. Upon completion of the intervention, the patient and caregiver will complete the follow up assessments at approximately 3 months and 6 months after the baseline questionnaires.
Eligibility Criteria
You may qualify if:
- Patient
- Diagnosed with cancer
- Screens positive for sleep problems (5 or greater score on the PSQI)
- Shares a bed with the caregiver/intimate partner
- Patient's caregiver/intimate partner also screens positive for sleep problems (5 or greater score on the PSQI)
You may not qualify if:
- Patient or Caregiver
- does not screen positive for sleep problems
- has been diagnosed with sleep apnea or use a continuous positive airway pressure (CPAP) machine
- has been diagnosed with narcolepsy or restless legs
- works in a job that requires shift changes
- does not speak/read English
- does not share a bed with intimate partner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh Medical Center Montefiore Liver Cancer Center
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer L Steel, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Research Coordinators will be masked
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 16, 2021
First Posted
July 20, 2021
Study Start
December 5, 2016
Primary Completion
April 4, 2026
Study Completion
April 4, 2026
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will be available at the end of the study for up to one year.
- Access Criteria
- Appropriate investigator credentials (MD, PhD) and request, and for up to one year after study completion
De-Identified Data may be shared with investigators who request data from the Primary Investigator